View Older Stories View More Recent Stories

Dec 11, 2023 09:00AM IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
Dec 8, 2023 04:01PM EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
Dec 7, 2023 11:00AM Simply Homes Secures $22M to Expand US Affordable Housing
Dec 7, 2023 07:02AM 89bio Inc. (ETNB) Announces Upsized Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
Dec 7, 2023 07:00AM 89bio, Inc. Announces Upsized Pricing of $150.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Dec 7, 2023 05:18AM AbbVie (ABBV) to acquire Cerevel (CERE) for $8.7 billion; deal 'makes sense' says analyst
Dec 6, 2023 05:42PM KBRA Assigns Rating to Cantor Fitzgerald, L.P.’s Senior Unsecured Notes Issue
Dec 6, 2023 04:36PM 89bio Inc. (ETNB) Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Dec 6, 2023 04:36PM 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Dec 6, 2023 06:09AM EyePoint Pharmaceuticals (EYPT) prices upsized 11.76M share offering at $17
Dec 5, 2023 08:18PM EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
Dec 5, 2023 05:01PM Form 8-K Cantor Fitzgerald Income For: Dec 05
Dec 5, 2023 06:06AM Analysis-Stock-hungry volatility funds, ‘gamma-heavy' options dealers could buoy US equities
Dec 1, 2023 10:13AM Novo Nordisk (NVO) outsized growth 'likely to continue to exceed Street expectations' - Cantor Fitzgerald
Dec 1, 2023 06:01AM Cantor Fitzgerald Starts Novo Nordisk (NVO) at Overweight, 'runway for obesity remaining attractive for years to come'
Nov 29, 2023 02:37PM XBP Europe Completes Business Combination with CF Acquisition Corp. VIII
Nov 29, 2023 09:04AM Form NPORT-P CANTOR FITZGERALD INFRAS For: Sep 30
Nov 29, 2023 06:46AM Cantor Fitzgerald Starts Microvast (MVST) at Overweight
Nov 29, 2023 06:45AM Cantor Fitzgerald Starts MedEquities Realty Trust (MRT) at Overweight
Nov 22, 2023 09:55AM GitLab Inc (GTLB) a generative AI innovation leader in DevSecOps - Cantor Fitzgerald
Nov 22, 2023 06:07AM Cantor Fitzgerald Starts GitLab Inc (GTLB) at Overweight, 'GitLab is poised to gain market share by collapsing legacy or point solution providers one by one'
Nov 21, 2023 05:14PM Marti Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants
Nov 21, 2023 06:22AM Cantor Fitzgerald Downgrades Mainz Biomed B.V. (MYNZ) to Neutral
Nov 20, 2023 09:09AM Sprott Physical Uranium Trust Announces Updated “At-the-Market” Equity Program
Nov 20, 2023 02:00AM Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
Nov 17, 2023 05:01PM Form 424B3 Cantor Fitzgerald Income
Nov 17, 2023 03:02PM Hefty options 'disaster hedges' draw buyers as US stocks extend rally
Nov 17, 2023 11:00AM Fannie Mae Prices $609 Million Connecticut Avenue Securities (CAS) REMIC Deal
Nov 17, 2023 10:53AM Form N-23C3A CANTOR FITZGERALD INFRAS For: Nov 17
Nov 16, 2023 08:03AM Mainz Biomed (MYNZ) Reports Q3 Results
Nov 16, 2023 08:01AM Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Nov 15, 2023 04:50PM Orchid Island Capital Announces November 2023 Monthly Dividend and October 31, 2023 RMBS Portfolio Characteristics
Nov 15, 2023 06:34AM Cantor Fitzgerald Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral, 'Getting Out of This Value Trap'
Nov 14, 2023 09:05PM Form 13F-NT Cantor Fitzgerald Europe For: Sep 30
Nov 14, 2023 08:59PM Form 13F-NT CANTOR FITZGERALD SECURI For: Sep 30
Nov 14, 2023 08:50PM Form 13F-HR CANTOR FITZGERALD, L. For: Sep 30
Nov 14, 2023 08:38PM Form 13F-NT CANTOR FITZGERALD INVEST For: Sep 30
Nov 14, 2023 06:53PM Form 13F-NT CANTOR FITZGERALD & CO. For: Sep 30
Nov 14, 2023 04:15PM View Announces Q3 2023 Earnings
Nov 14, 2023 02:31PM Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
Nov 14, 2023 07:31AM Alaunos Therapeutics (TCRT) Reports Q3, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Nov 14, 2023 07:30AM Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Nov 14, 2023 06:12AM Form 10-Q Cantor Fitzgerald Income For: Sep 30
Nov 10, 2023 02:52PM Cantor Fitzgerald cuts 2U (TWOU) to Neutral as tech firm faces debt maturity
Nov 10, 2023 08:00AM LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions
Nov 10, 2023 05:58AM Cantor Fitzgerald Starts NeuroPace Inc (NPCE) at Overweight, 'Wired for Success'
Nov 10, 2023 03:58AM Cantor Fitzgerald Downgrades 2U, Inc. (TWOU) to Neutral
Nov 8, 2023 11:22AM Investors spurn options hedges as U.S. stock rally crushes fear
Nov 8, 2023 08:34AM Cantor Fitzgerald cuts Lucid (LCID) to Neutral following 3Q revenue miss
Nov 8, 2023 06:05AM Cantor Fitzgerald Downgrades Lucid Group Inc. (LCID) to Neutral, 'lower expected revenues'
View More Recent Stories View Older Stories